BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38240343)

  • 1. Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews.
    Todd A; Waldron C; McGeagh L; Norris R; Bolnykh I; Stewart SJ; Slodkowska-Barabasz J; Moon Z; Cahir C; Thompson S; Harmer V; Wells M; Watson E; Sharp L;
    Cancer Med; 2024 Feb; 13(3):e6937. PubMed ID: 38240343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis.
    Peddie N; Agnew S; Crawford M; Dixon D; MacPherson I; Fleming L
    Breast; 2021 Aug; 58():147-159. PubMed ID: 34049260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review.
    Prajapati AR; Dima A; Mosa G; Scott S; Song F; Wilson J; Bhattacharya D
    Psychol Med; 2021 May; 51(7):1082-1098. PubMed ID: 34006337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
    Lambert LK; Balneaves LG; Howard AF; Gotay CC
    Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up Routines Matter for Adherence to Endocrine Therapy in the Adjuvant Setting of Breast Cancer.
    Aurell C; Haidar A; Giglio D
    Breast Cancer (Auckl); 2024; 18():11782234241240171. PubMed ID: 38628960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
    Cavazza M; Banks H; Ercolanoni M; Cukaj G; Bianchi G; Capri G; Longo F
    Breast Cancer Res Treat; 2020 Aug; 183(1):189-199. PubMed ID: 32591986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
    Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
    Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of patient adherence: a review of systematic reviews.
    Kardas P; Lewek P; Matyjaszczyk M
    Front Pharmacol; 2013; 4():91. PubMed ID: 23898295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
    Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review.
    Toivonen KI; Williamson TM; Carlson LE; Walker LM; Campbell TS
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33561076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors.
    Paranjpe R; John G; Trivedi M; Abughosh S
    Breast Cancer Res Treat; 2019 Apr; 174(2):297-305. PubMed ID: 30523459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients.
    Haji-Hersi MF; Tilley S; Shelton CA; Lamb N; Kamdem LK
    J Oncol Pharm Pract; 2022 Jul; 28(5):1070-1076. PubMed ID: 34053357
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.